{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:59:24Z","timestamp":1791831564335,"version":"4.3.4"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000725","name":"The","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007155","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/X030466\/1"],"award-info":[{"award-number":["MR\/X030466\/1"]}],"id":[{"id":"10.13039\/501100007155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Alopecia areata (AA) can significantly impact patients\u2019 quality of life (QoL) and mental health, leading to increased levels of anxiety and depression. It is unclear whether this impact is more strongly associated with disease severity or patients\u2019 disease perception, and which patients are more likely to have a greater psychological burden.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To examine the psychosocial impact of AA, while focusing on illness perceptions and stigma, aiming to identify high-risk subgroups and key perceptions linked to worse QoL, anxiety and depression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was a UK cross-sectional online study. It comprised 596 patients with AA who self-reported disease severity and completed the Dermatology Life Quality Index (DLQI), EuroQol 5-Dimensional 5-Level (EQ-5D-5L), Hospital Anxiety and Depression Scale (HADS), Stigma Scale for Chronic Illnesses 8-Item (SSCI-8) and Brief Illness Perception Questionnaire (BIPQ).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Patients with AA perceived their condition as chronic and life-impacting, with limited personal or treatment control, significant emotional effects and high concern. Many patients reported high levels of anxiety, depression, stigma and impaired QoL, all strongly associated with illness perceptions. Hierarchical regression analyses showed that illness perceptions and stigma explained a higher proportion of variance in QoL, anxiety and depression than disease severity. Cluster analysis identified two distinct patient groups based on illness perceptions, with different levels of QoL, anxiety, depression and stigma.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>AA has a severe psychosocial impact, more strongly linked to patients\u2019 illness perceptions and stigma than disease severity. The identification of two distinct patient profiles based on illness perceptions reveals differences in psychosocial burden, highlighting those at risk of worse outcomes and underscoring the value of evaluating illness perceptions along with stigma in clinical practice to improve patient outcomes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bjd\/ljaf189","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T07:55:51Z","timestamp":1747382151000},"page":"458-467","source":"Crossref","is-referenced-by-count":24,"title":["Psychosocial burden and the impact of illness perceptions and stigma on quality of life, anxiety and depression in alopecia areata: results from the Alopecia + Me study"],"prefix":"10.1093","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8308-5705","authenticated-orcid":false,"given":"Evangelos","family":"Christou","sequence":"first","affiliation":[{"name":"St John\u2019s Institute of Dermatology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolina","family":"Lalagianni","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7977-6028","authenticated-orcid":false,"given":"Sheila M","family":"McSweeney","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Cotter","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuin Ying","family":"Ung","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Walburn","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Science, Franklin-Wilkins Building, School of Cancer and Pharmaceutical Sciences, King\u2019s College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"McCrone","sequence":"additional","affiliation":[{"name":"The Institute for Lifecourse Development, University of Greenwich , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8210-1011","authenticated-orcid":false,"given":"Mark A","family":"Turner","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3708-9964","authenticated-orcid":false,"given":"John A","family":"McGrath","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Weinman","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Science, Franklin-Wilkins Building, School of Cancer and Pharmaceutical Sciences, King\u2019s College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1662-4494","authenticated-orcid":false,"given":"Christos","family":"Tziotzios","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"issue":"Suppl. 4","key":"2025081809373180000_ljaf189-B1","first-page":"P67","article-title":"Overall lifetime risk for alopecia areata is 2.1% and is higher in women, non-White ethnic groups and the most deprived: a UK population-based cohort study","volume":"188","author":"Thompson","year":"2023","journal-title":"Br J Dermatol"},{"key":"2025081809373180000_ljaf189-B2","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/jid.2013.464","article-title":"Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990-2009","volume":"134","author":"Mirzoyev","year":"2014","journal-title":"J Invest Dermatol"},{"key":"2025081809373180000_ljaf189-B3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/bjd.20628","article-title":"The epidemiology of alopecia areata: a population-based cohort study in UK primary care","volume":"186","author":"Harries","year":"2022","journal-title":"Br J Dermatol"},{"key":"2025081809373180000_ljaf189-B4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/bjd.21055","article-title":"The associated burden of mental health conditions in alopecia areata: a population-based study in UK primary care","volume":"187","author":"Macbeth","year":"2022","journal-title":"Br J Dermatol"},{"key":"2025081809373180000_ljaf189-B5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jamadermatol.2022.6085","article-title":"Prevalence and odds of depressive and anxiety disorders and symptoms in children and adults with alopecia areata: a systematic review and meta-analysis","volume":"159","author":"Lauron","year":"2023","journal-title":"JAMA Dermatol"},{"key":"2025081809373180000_ljaf189-B6","doi-asserted-by":"crossref","first-page":"1054898","DOI":"10.3389\/fmed.2022.1054898","article-title":"Anxiety, depression, and quality of life in children and adults with alopecia areata: a systematic review and meta-analysis","volume":"9","author":"van Dalen","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"2025081809373180000_ljaf189-B7","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1185\/030079905X61820","article-title":"The psychosocial impact of hair loss among men: a multinational European study","volume":"21","author":"Alfonso","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"2025081809373180000_ljaf189-B8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0738-081X(00)00127-9","article-title":"The psychology of hair loss and its implications for patient care","volume":"19","author":"Cash","year":"2001","journal-title":"Clin Dermatol"},{"key":"2025081809373180000_ljaf189-B9","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/bjd.17463","article-title":"Living with alopecia areata: an online qualitative survey study","volume":"180","author":"Davey","year":"2019","journal-title":"Br J Dermatol"},{"key":"2025081809373180000_ljaf189-B10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jaad.2020.06.047","article-title":"Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: a systematic review","volume":"85","author":"Toussi","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"2025081809373180000_ljaf189-B11","doi-asserted-by":"crossref","first-page":"536","DOI":"10.7861\/clinmedicine.6-6-536","article-title":"Why illness perceptions matter","volume":"6","author":"Petrie","year":"2006","journal-title":"Clin Med (Lond)"},{"key":"2025081809373180000_ljaf189-B12","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/bjd.17123","article-title":"To what extent do disease severity and illness perceptions explain depression, anxiety and quality of life in hidradenitis suppurativa?","volume":"180","author":"Pavon Blanco","year":"2019","journal-title":"Br J Dermatol"},{"key":"2025081809373180000_ljaf189-B13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0022-3999(02)00455-5","article-title":"The role of illness severity and illness representations in adjusting to multiple sclerosis","volume":"54","author":"Jopson","year":"2003","journal-title":"J\u00a0Psychosom Res"},{"key":"2025081809373180000_ljaf189-B14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40359-014-0050-3","article-title":"The contribution of illness perception to psychological distress in heart failure patients","volume":"2","author":"Morgan","year":"2014","journal-title":"BMC Psychol"},{"key":"2025081809373180000_ljaf189-B15","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/j.1365-2133.2008.09014.x","article-title":"Illness perceptions, coping and quality of life in patients with alopecia","volume":"160","author":"Cartwright","year":"2009","journal-title":"Br J Dermatol"},{"key":"2025081809373180000_ljaf189-B16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/jamadermatol.2024.0594","article-title":"Stigmatization and mental health impact of chronic pediatric skin disorders","volume":"160","author":"Paller","year":"2024","journal-title":"JAMA Dermatol"},{"key":"2025081809373180000_ljaf189-B17","doi-asserted-by":"crossref","first-page":"e0205009","DOI":"10.1371\/journal.pone.0205009","article-title":"Stigma predicts health-related quality of life impairment, psychological distress, and somatic symptoms in acne sufferers","volume":"13","author":"Davern","year":"2018","journal-title":"PLOS ONE"},{"key":"2025081809373180000_ljaf189-B18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)\u2013a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"2025081809373180000_ljaf189-B19","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.0022-202X.2005.23621.x","article-title":"Translating the science of quality of life into practice: what do dermatology life quality index scores mean?","volume":"125","author":"Hongbo","year":"2005","journal-title":"J Invest Dermatol"},{"key":"2025081809373180000_ljaf189-B20","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"key":"2025081809373180000_ljaf189-B21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hec.3564","article-title":"Valuing health-related quality of life: An EQ-5D-5L value set for England","volume":"27","author":"Devlin","year":"2018","journal-title":"Health Econ"},{"key":"2025081809373180000_ljaf189-B22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"2025081809373180000_ljaf189-B23","volume-title":"The Hospital Anxiety and Depression Scale with the Irritability-Depression-Anxiety Scale and the Leeds Situational Anxiety Scale: Manual","author":"Snaith"},{"key":"2025081809373180000_ljaf189-B24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","article-title":"The validity of the Hospital Anxiety and Depression Scale:","volume":"52","author":"Bjelland","year":"2002","journal-title":"An updated literature review. J\u00a0Psychosom Res"},{"key":"2025081809373180000_ljaf189-B25","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s12529-012-9243-4","article-title":"The stigma scale for chronic illnesses 8-item version (SSCI-8): development, validation and use across neurological conditions","volume":"20","author":"Molina","year":"2013","journal-title":"Int J Behav Med"},{"key":"2025081809373180000_ljaf189-B26","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jpsychores.2005.10.020","article-title":"The brief illness perception questionnaire","volume":"60","author":"Broadbent","year":"2006","journal-title":"J Psychosom Res"},{"key":"2025081809373180000_ljaf189-B27","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1080\/08870446.2015.1070851","article-title":"A systematic review and meta-analysis of the Brief Illness Perception Questionnaire","volume":"30","author":"Broadbent","year":"2015","journal-title":"Psychol Health"},{"key":"2025081809373180000_ljaf189-B28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/14768320600774496","article-title":"Cluster analysis in illness perception research: a Monte Carlo study to identify the most appropriate method","volume":"22","author":"Clatworthy","year":"2007","journal-title":"Psychol Health"},{"key":"2025081809373180000_ljaf189-B29","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/bjd.14497","article-title":"Alopecia areata and health-related quality of life: a systematic review and meta-analysis","volume":"175","author":"Rencz","year":"2016","journal-title":"Br J Dermatol"},{"key":"2025081809373180000_ljaf189-B30","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4103\/0019-5154.135525","article-title":"The relationship between alopecia areata and alexithymia, anxiety and depression: a case-control study","volume":"59","author":"Sellami","year":"2014","journal-title":"Indian J Dermatol"},{"key":"2025081809373180000_ljaf189-B31","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s13555-023-00941-z","article-title":"The invisible impact of a visible disease: psychosocial impact of alopecia areata","volume":"13","author":"Mesinkovska","year":"2023","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2025081809373180000_ljaf189-B32","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/0961203310385552","article-title":"Illness perceptions in patients with systemic lupus erythematosus and proliferative lupus nephritis","volume":"20","author":"Daleboudt","year":"2011","journal-title":"Lupus"},{"key":"2025081809373180000_ljaf189-B33","doi-asserted-by":"crossref","first-page":"e187430642112141","DOI":"10.2174\/18743064-v16-e2112141","article-title":"Identification of different profiles of illness perception in COPD patients: results of\u00a0cluster analysis","volume":"16","author":"Ovcharenko","year":"2022","journal-title":"Open Respir Med J"},{"key":"2025081809373180000_ljaf189-B34","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1037\/hea0001192","article-title":"Illness perception profiles and psychological and physical symptoms in newly diagnosed advanced non-small cell lung cancer","volume":"41","author":"Valentine","year":"2022","journal-title":"Health Psychology"},{"key":"2025081809373180000_ljaf189-B35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jpsychores.2008.12.001","article-title":"Further development of an illness perception intervention for myocardial infarction patients:\u00a0a randomized controlled trial","volume":"67","author":"Broadbent","year":"2009","journal-title":"J Psychosom Res"},{"key":"2025081809373180000_ljaf189-B36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jpsychores.2008.11.006","article-title":"Can an illness perception intervention reduce illness anxiety in spouses of myocardial infarction patients? A randomized controlled trial","volume":"67","author":"Broadbent","year":"2009","journal-title":"J Psychosom Res"},{"key":"2025081809373180000_ljaf189-B37","first-page":"105","article-title":"Psychological family intervention for poorly controlled type 2 diabetes","volume":"17","author":"Keogh","year":"2011","journal-title":"Am J Manag Care"},{"key":"2025081809373180000_ljaf189-B38","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s12160-017-9885-1","article-title":"A self-regulatory intervention for patients with head and neck cancer: pilot randomized trial","volume":"51","author":"Richardson","year":"2017","journal-title":"Ann Behav Med"},{"key":"2025081809373180000_ljaf189-B39","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/jdv.15734","article-title":"Strategies to reduce stigma related to visible chronic skin diseases: a systematic review","volume":"33","author":"Topp","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025081809373180000_ljaf189-B40","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1007\/s13555-023-01057-0","article-title":"Physician- and patient-reported severity and quality of life impact of alopecia areata: results from a real-world survey in five European countries","volume":"13","author":"Vano-Galvan","year":"2023","journal-title":"Dermatol Ther (Heidelb)"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljaf189\/63215917\/ljaf189.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/193\/3\/458\/63215917\/ljaf189.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/193\/3\/458\/63215917\/ljaf189.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T13:37:42Z","timestamp":1755524262000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/193\/3\/458\/8134189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,7,16]]},"published-print":{"date-parts":[[2025,8,18]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljaf189","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,7,16]]}}}